Clinical Trial Update: Safety and Efficacy Study for AKB-6548 in Participants With Chronic Kidney Disease and Anemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing safety and efficacy of AKB-6548 in adults with chronic kidney disease and anemia has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• AKB-6548

Snippet

Sponsor: Akebia Therapeutics | Conditions: Anemia, Kidney Disease | Phase 2 | Status: COMPLETED | Results posted: 2022-07-01